Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Active not recruiting 4Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 5

Conditions

Leukemia, Myeloid, Acute 311Leukemia, Lymphocytic, Chronic, B-Cell 108Myelodysplastic Syndromes 63Recurrence 55Leukemia 43Neoplasms 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma, Non-Hodgkin 41Lymphoma, Mantle-Cell 32Multiple Myeloma 28Lymphoma, Large B-Cell, Diffuse 27Leukemia, Myelomonocytic, Chronic 27Lymphoma, Follicular 22Lymphoma 21Hematologic Neoplasms 20Lymphoma, B-Cell, Marginal Zone 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia, Biphenotypic, Acute 16Burkitt Lymphoma 16Myeloproliferative Disorders 11Lymphoma, B-Cell 11Leukemia, Myeloid 11Neoplasm, Residual 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Waldenstrom Macroglobulinemia 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Chromosome 17 deletion 6Leukemia, B-Cell 5Immunoglobulin Light-chain Amyloidosis 5Breast Neoplasms 5

Interventions

Cyclophosphamide 18ofatumumab 14fludarabine 12Rituximab 11ibrutinib 10fludarabine phosphate 9acalabrutinib 7obinutuzumab 6Lenalidomide 6Bendamustine Hydrochloride 6venetoclax 5pirtobrutinib 4Vincristine 4Mesna 4Melphalan 4Immunotherapy, Adoptive 4Whole-Body Irradiation 3Mycophenolic Acid 3Chlorambucil 3Bortezomib 3Alemtuzumab 3spebrutinib 2navitoclax 2idelalisib 2Tacrolimus 2Tablets 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2KW-2478 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Leukemia, B-Cell × venetoclax × Clear all
NCT04608318 2026-04-30

CLL17

German CLL Study Group

Phase 3 Active not recruiting
897 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03766763 2025-11-26

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

French Innovative Leukemia Organisation

Phase 2 Active not recruiting
82 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT04515238 2025-06-10

CLL2-BZAG

German CLL Study Group

Phase 2 Active not recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03787264 2024-12-30

CLL2-BAAG

German CLL Study Group

Phase 2 Completed
46 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03836261 2024-12-27

AMPLIFY

Acerta Pharma BV

Phase 3 Active not recruiting
984 enrolled 1 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡